Webinar Replay: "Canine Vector-Borne Diseases- Diagnosis in the Companion Animal Practice"

Is this email not displaying correctly? View it in your browser.

Webinar Replay: "Canine Vector-Borne Diseases- Diagnosis in the Companion Animal Practice"

The free access webinar “Canine Vector-Borne Diseases - Diagnosis in the Companion Animal Practice” was held on Tuesday, Jan. 25, 2022, at 7:00 PM (GMP +8). During the lecture, Dr. Joel P. Tolentino shared the cause, symptoms, treatment, and diagnosis of Anaplasmosis, Babesiosis, Ehrlichiosis, and Heartworms in dogs. He also explained the importance of early detection to cure the infected dogs in the companion animal practice.

The webinar was very successful so, we thank you for participating in the event! You can watch the replay of the webinar by visiting our Youtube channel and Facebook page. You can also scan the QR code below to visit the pages. It is free to share the link with your friends or colleagues who might be interested to learn about the canine vector-borne disease.

An Update on the Practical Use of NT-proBNP in Dogs and Cats

There are several indications for the clinical use of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in aiding clinical decision making where access to echocardiography is limited.

N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of myocardial stretch. Increased circulating concentrations are associated with increased filling pressures which occur in several important cardiac diseases, including myxomatous mitral valve disease (MMVD), dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM). This biomarker can aid clinical decision making in patients where access to echocardiography is limited.

Bioguard is Glad to Wish You a Happy Lunar New Year 2022

Bioguard team take the privilege to wish you with your family a Happy Lunar New Year 2021.

May this year bring you peace, success and joy on your journey!

Bioguard.

The VLabs 4BX is Unique for Detecting Vector Borne Diseases

Canine vector-borne diseases (CVBDs) are caused by a range of pathogens transmitted to dogs by blood-feeding arthropods, e.g. ticks, fleas, mosquitoes and sand flies. These diseases are a growing global threat and in some cases also have zoonotic consequences.

The VLab 4BX is a sandwich lateral flow immunochromatographic assay, developed and manufactured by Bioguard Corporation. This 4-in-1 combo test offers a unique combination for veterinarians to detect canine heartworm Ag, Babesia gibsoni Ab, Ehrlichia canis Ab, and Anaplasma Ab at the same time. Currently, VLab 4BX is the only 4-in-1 combo test including detection of B. gibsoni Ab on the market.

CVBDs pose a diagnostic challenge, particularly when a dog is co-infected with more than one pathogen. Sometimes, the infected dogs may not show any symptoms, and the best possible and easy way to detect these diseases is to use a diagnostic tool like the VLabs 4BX.

Prompt diagnosis of dogs infected with these pathogens plays an important role in treatment and prevention of the disease.

To know more about VLab 4BX, please click here

About Bioguard Corporation

The Bioguard is a company focusing on animal

disease diagnostic services and products.
Our animal health diagnostic center is

the first and only ISO/ IEC 17025 accredited animal disease testing laboratory

in Taiwan and China.

Our mailing address is: [email protected]

If you want to unsubscribe, click here.